Favorable effects of supplemental orinase in insulin-treated labile diabetes.
D003922:Diabetes Mellitus, Type 1; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use*; D014044:Tolbutamide
D007004:Hypoglycemic Agents; D007328:Insulin; D014044:Tolbutamide
ANTIDIABETICS/therapeutic use; INSULIN/therapeutic use